Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases. Hepatology. 2021;73(1):366–413
Intagliata NM, Rahimi RS, Higuera-de-la-Tijera F, Simonetto DA, Farias AQ, Mazo DF, et al. Procedural-related bleeding in hospitalized patients with liver disease (PROC-BLeeD): an international, prospective. Multicent Obs Study Gastroenterol. 2023;165(3):717–732
Spyropoulos AC, Brohi K, Caprini J, Samama CM, Siegal D, Tafur A, et al. Scientific and standardization committee communication: guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk. J Thromb Haemost. 2019;17(11):1966–1972
Lin S, Wang M, Zhu Y, Dong J, Weng Z, Shao L, et al. Hemorrhagic complications following abdominal paracentesis in acute on chronic liver failure: a propensity score analysis. Medicine (Baltimore). 2015;94(49): e2225
European Association for the Study of the Liver. EASL clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol. 2022;76(5):1151–1184
Roberts LN, Lisman T, Stanworth S, Hernandez-Gea V, Magnusson M, Tripodi A, et al. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH. J Thromb Haemost. 2022;20(1):39–47
Article CAS PubMed Google Scholar
Patel IJ, Rahim S, Davidson JC, Hanks SE, Tam AL, Walker TG, et al. Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions-part ii: recommendations: endorsed by the Canadian association for interventional radiology and the cardiovascular and interventional radiological society of europe. J Vasc Interv Radiol. 2019;30(8):1168–1184
De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology. 2016;63(2):566–573
Vuyyuru SK, Singh AD, Gamanagatti SR, Rout G, Gunjan D, Shalimar A. Randomized control trial of thromboelastography-guided transfusion in cirrhosis for high-risk invasive liver-related procedures. Dig Dis Sci. 2020;65(7):2104–2111
Article CAS PubMed Google Scholar
Maria A, Lal BB, Khanna R, Sood V, Mukund A, Bajpai M, et al. Rotational thromboelastometry-guided blood component use in cirrhotic children undergoing invasive procedures: Randomized controlled trial. Liver Int. 2022;42(11):2492–2500
Article CAS PubMed Google Scholar
Kumar R, Louis Ng XL, Wong YJ, Tan CK, Wang LZ, Qiu TY, Wong B, Lin KW, Eu Kwek AB, Gokhle RS, Sivanath TP. Rotational Thromboelastometry (ROTEM) reduces the need for pre-emptive transfusion in cirrhosis: A randomized controlled Trial (NCT:05698134). Research Square 2024. https://assets-eu.researchsquare.com/files/rs-4329141/v1/b2dfa98c-46cc-4d36-addb-a010a0b94b3d.pdf?c=1716597832. Accessed May 27, 2024.
International Society of Blood Transfusion; Working Party on Haemovigilance. Proposed standard definitions for surveillance of non-infectious adverse transfusion reactions. http://www.isbtweb.org/fileadmin/user_upload/Proposed_definitions_2011_surveillance_non_infectious_adverse_reactions_haemovigilance_incl_TRALI_correction _2013.pdf ( Accessed 30 December 2022).
Vinson DR, Ballard DW, Hance LG, Hung Y, Rauchwerger AS, Reed ME, et al. Bleeding complications of central venous catheterization in septic patients with abnormal hemostasis. Am J Emerg Med. 2014;32(7):737–742
Kitchin DR, Del Rio AM, Woods M, Ludeman L, Hinshaw JL. Percutaneous liver biopsy and revised coagulation guidelines: a 9-year experience. Abdom Radiol (NY). 2018;43(6):1494–1501
Ahmed O, Ward TJ, Lungren MP, et al. Assessing the risk of hemorrhagic complication following transjugular liver biopsy in bone marrow transplantation recipients. J Vasc Interv Radiol. 2016;27:551–557
Dariushnia SR, Haskal ZJ, Midia M, Martin LG, Walker TG, Kalva SP, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 2016;27(1):1–7
Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 Published: November 27, 2017. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. National Institutes of Health. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf (Accessed on 30 December 2022).
Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390
European Association for the Study of the Liver. EASL clinical practice guidelines on acute-on-chronic liver failure. J Hepatol. 2023;79(2):461–491
Bezinover D, Dirkmann D, Findlay J, Guta C, Hartmann M, Nicolau-Raducu R, et al. Perioperative coagulation management in liver transplant recipients. Transplantation. 2018;102(4):578–592
Gorlinger K. Coagulation management during liver transplantation. Hamostaseologie. 2006;26:S64–S76
Article CAS PubMed Google Scholar
Rocha LL, Neto AS, Pessoa CMS, Almeida MD, Juffermans NP, Crochemore T, et al. Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis: a randomized controlled trial. J Thromb Haemost. 2020;18(3):560–570
Lisman T, Kleiss S, Patel VC, Fisher C, Adelmeijer J, Bos S, et al. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver Int. 2018;38(11):1988–1996
Article CAS PubMed PubMed Central Google Scholar
Rassi AB, d’Amico EA, Tripodi A, da Rocha TRF, Migita BY, Ferreira CM, et al. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation. J Hepatol. 2020;72(1):85–94
Article CAS PubMed Google Scholar
Tripodi A, Primignani M, Chantarangkul V, Lemma L, Jovani M, Rebulla P, et al. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion. Liver Int. 2013;33(3):362–367
Zanetto A, Rinder HM, Campello E, et al. Acute kidney injury in decompensated cirrhosis is associated with both hypo-and hyper-coagulable features. Hepatology. 2020;72:1327–1340
Article CAS PubMed Google Scholar
Hung A, Garcia-Tsao G. Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis. Liver Int. 2018;38:1437–1441
Article PubMed PubMed Central Google Scholar
Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol. 2002;37:463–470
Article CAS PubMed Google Scholar
Lin S, Wang M, Zhu Y, et al. Hemorrhagic complications following abdominal paracentesis in acute on chronic liver failure: a propensity score analysis. Medicine (Baltimore). 2015;94: e2225
Comments (0)